4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-22-010392
Chief Scientific Officer bought 3,250 shares at $0.46 ($1,495)
From the SEC's structured data for this filing
Trades in this filing
Blouse Grant E. · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-09 | Purchase : show line 1 in the form | +3,250 | $0.46 | $1,495 | 6,167 | D |
| Open-market purchases · 3,250 sh · avg $0.46 · $1,495 | ||||||
Loading xslF345X03/doc4.xml…